PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Aug-2022 Sakuu Opens New Battery Printing and Engineering Facility in Silicon Valley Businesswire
04-Aug-2022 Endologix Receives CE Mark Certification under EU-MDR for AFX®2 Endovascular AAA System Businesswire
04-Aug-2022 Organon Reports Results for the Second Quarter Ended June 30, 2022 Businesswire
04-Aug-2022 TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insights Report 2022-2028 - ResearchAndMarkets.com Businesswire
04-Aug-2022 Virios Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Thursday, August 11, 2022 Businesswire
04-Aug-2022 Chinese Digestive Remedies Market Report 2022:: Demand for Digestive Remedies will continue to grow at 6% by 2031 - ResearchAndMarkets.com Businesswire
04-Aug-2022 The IBSA Class40 – the Craft That Will Take Alberto Bona to the Route Du Rhum – Was Launched in Trinité-Sur-Mer Businesswire
04-Aug-2022 invoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc. Businesswire
04-Aug-2022 Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand Businesswire
04-Aug-2022 BeiGene Reports Second Quarter 2022 Financial Results Businesswire
04-Aug-2022 Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update Businesswire
04-Aug-2022 Aptar Pharma Acquires Worldwide License for Orbital™ High Payload Dry Powder Inhaler Aptar Pharma
04-Aug-2022 Global Photoinitiator Market to Reach $1.6 Billion by 2027 - ResearchAndMarkets.com Businesswire
04-Aug-2022 Fera Science launches £1m Laboratory for Insect Bioconversion at York base Fera Science
04-Aug-2022 Oxford Science Enterprises portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million Oxford Science Enterprises
04-Aug-2022 ProQR Announces Second Quarter 2022 Operating and Financial Results ProQR
04-Aug-2022 Bayer tops the Equality, Diversity and Inclusion leader board in multibillion pharma industry Alva
04-Aug-2022 Global Cell Separation Market to Reach $16.37 Billion by 2027 - ResearchAndMarkets.com Businesswire
04-Aug-2022 University of Birmingham signs licensing deal with world’s largest COVID-19 test provider to commercialise novel testing method University of Birmingham
04-Aug-2022 LYNPARZA® (olaparib) Approved in the EU as Adjuvant Treatment for Patients With Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer Businesswire